Shares of Edesa Biotech Inc (NASDAQ:EDSA) surged after the biotech company was granted regulatory approval to initiate COVID-19 study. The company has been granted expedited approval by Health Canada to start a Phase 2/3 clinical study into EB05. Edesa's investigational drug being developed to treat moderate to severe COVID-19...
RXi Pharmaceuticals Corp (NASDAQ:RXII) has entered into a collaborative accord with Karolinska Institutet for the development of sd-rxRNA compounds that improves persistence and functionality of NK Cells and T Cells. The T cells and NK Cells will help to advance the Immuno oncology for the treatment of solid tumors....
vTv Therapeutics Inc (NASDAQ:VTVT) is a clinical stage pharmaceutical business that focuses on the development of solutions for unmet medical needs. The company unveiled its second quarter financial results for June 30, 2018 today. Asides from that, it has also given updates regarding the upcoming events as well as...
TrovaGene Inc (NASDAQ:TROV) is aclinical-stage oncology therapeutics provider manufactures drugs that help towards the treatment of a wide range of conditions. These include the solid tumor cancers, lymphomas and leukemias. A close outlook Trovagene, Inc says that the previous dosing cohort of Onvansertib was a major success and the second is...
CorMedix Inc (NYSEAMERICAN:CRMD) is a biopharmaceutical company that focuses on the manufacture of therapeutic products. These products play a major role in the treatment and prevention of inflammatory and infectious diseases. A close outlook This business guru unveiled the financial results for the second quarter and still went ahead to give...
GTx, Inc (NASDAQ:GTXI) has unveiled results for its recent trial. It was a study to evaluate enobosarm in post-menopausal women struggling with stress urinary incontinence (SUI).The orally-administered enobosarm didn’t sufficiently separate from the placebo. The turn of events GTx, Inc outlines that it conducted the enobosarm treatment over a period of...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s Ex-CEO Michael Pearson has been accused of unheeding the possibility of corruption in its option-purchase agreement with Philidor Rx Services LLC by the star witness from the side of government, Laizer Kornwasser. The former official of Valeant testified during a cross-examination that Pearson was...
Merck & Co., Inc. (NYSE:MRK) and US biotech startup Moderna Therapeutics have moved their 2016 partnership a step further by agreeing to share antigen mRNA cancer vaccines including mRNA-5671. Under the initial partnership, the two companies agreed to jointly develop and commercialize novel personalized messenger RNA (mRNA) cancer vaccines. Moderna...
Anthem Inc (NYSE:ANTM) is a leading health insurance company that has been competing at all levels with the leading health insurers of the country. But it seems it is not at all interested in the current high-power deals that are making a wave in the United States’ health insurance...
AbbVie Inc (NYSE:ABBV) has announced that it has signed an agreement with Samsung Bioepis plus its joint venture Biogen Inc (NASDAQ:BIIB) that will help reduce competition for their biosimilar version so as to boost Humira until 2023. This is the second agreement that the company has signed over the years...